Thus far, most of the biomarker studies have been focused on tumor signatures such as the expression of PD-L1, the instability of microsatellites, and tumor genomic mutation; however, there are far fewer studies investigating clinical biomarkers [13]. Here, CD274 is linked to neoplasm.